Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AQST - Aquestive Therapeutics: Looking To End 2021 On A Bullish Note


AQST - Aquestive Therapeutics: Looking To End 2021 On A Bullish Note

  • Aquestive Therapeutics is moving closer to Libervant’s PDUFA date in December. If approved, Aquestive will finish 2021 on a bullish note that can be sustained into 2022.
  • Aquestive has fought through COVID-19 headwinds and was able to report a strong beat on Q3 with SYMPAZAN continuing to show strong growth over the past 11 consecutive quarters.
  • The company’s AQST-109 epinephrine program reported impressive topline data from a PK study. If approved, AQST-109 could dethrone the EpiPen as the leader in the epinephrine market.
  • I discuss my plans for managing my AQST position ahead of the PDUFA date and potential approval.

For further details see:

Aquestive Therapeutics: Looking To End 2021 On A Bullish Note
Stock Information

Company Name: Aquestive Therapeutics Inc.
Stock Symbol: AQST
Market: NASDAQ
Website: aquestive.com

Menu

AQST AQST Quote AQST Short AQST News AQST Articles AQST Message Board
Get AQST Alerts

News, Short Squeeze, Breakout and More Instantly...